GlassScriptPhysician profile
Gilbert L Rogers
NPI 1356352553
$4,156.14
in general payments reported to CMS, 2019-2025
41 companies · $709 in 2025
The $709 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $991 · 2020: $170 · 2022: $472 · 2023: $1,088 · 2024: $726 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,523.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $547.26 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $424.46 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Novo Nordisk INC | $340.84 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $264.54 | 2019-2025 | |
| Amgen INC. | $217.87 | 2019-2025 | Evenity, Prolia, Repatha |
| Neurocrine Biosciences, INC. | $209.87 | 2023-2025 | Ingrezza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $184.08 | 2019-2025 | Xifaxan, Trulance |
| Novartis Pharmaceuticals Corporation | $171.89 | 2019-2025 | |
| Exact Sciences Corporation | $138.89 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $138.76 | 2019-2025 | Vraylar, Qulipta |
| Astellas Pharma US INC | $133.70 | 2019-2024 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $128.64 | 2019 | |
| Abbott Laboratories | $100.29 | 2019-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.77 | 2019-2025 | Jardiance |
| Sunovion Pharmaceuticals INC. | $86.67 | 2019-2020 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.